Keyphrases
Mitoxantrone Resistance
100%
Resistance Protein
100%
ABCG2
100%
Anti-peptide Antibody
100%
Epitope
22%
Plasma Membrane
22%
High Molecular Weight
11%
Mitoxantrone
11%
ABCG2 Gene
11%
Electron Microscopic
11%
N-linked Glycosylation
11%
Substrate Transport
11%
Non-reducing
11%
Crosslinking Agent
11%
Immunoblot Analysis
11%
Cytoplasmic Area
11%
Plasma Membrane Localization
11%
N-glycanase
11%
Denaturing Conditions
11%
Immunohistochemical Staining
11%
Molecular Size
11%
Dimerization
11%
Camptothecin
11%
Reducing Conditions
11%
Chorionic Villi
11%
Gene Overexpression
11%
Cancer Cell Lines
11%
High-affinity Antibodies
11%
Polyclonal Antibody
11%
Placenta
11%
Membrane Staining
11%
Western Blot Analysis
11%
Expression Level
11%
ATP-dependent
11%
Tunicamycin
11%
Medicine and Dentistry
Breast Cancer Resistance Protein
100%
Mitoxantrone
100%
Peptide Antibody
100%
Cell Membrane
27%
Epitope
18%
Tunicamycin
9%
Glycosidase
9%
Western Blot
9%
Cell Line
9%
Polyclonal Antibody
9%
Immunoblotting
9%
Placenta
9%
Camptothecin
9%
Antibody Affinity
9%
Gene Overexpression
9%
Glycosylation
9%
Cross Linking Reagent
9%
Dimer
9%
Adenosine Triphosphate
9%
Chorion Villus
9%
Cancer Cell Line
9%
Immunology and Microbiology
ABCG2
100%
Peptide Antibody
100%
Cell Membrane
27%
Molecular Weight
18%
Epitope
18%
Western Blot
18%
Dimerization
9%
Chorion Villus
9%
Antibody Affinity
9%
Peptides
9%
Cell Line
9%
Placenta
9%
Glycoside Hydrolase
9%
Molecular Size
9%
Cross Linking
9%
Glycosylation
9%
Cancer Cell Line
9%
Polyclonal Antibody
9%
Biochemistry, Genetics and Molecular Biology
ABCG2
100%
Cell Membrane
27%
Molecular Weight
18%
Cancer Cell
9%
Immunoblotting
9%
Gene Overexpression
9%
Glycoside Hydrolase
9%
Molecular Size
9%
Western Blot
9%
N-Linked Glycosylation
9%
Cross-Link
9%
Adenosine Triphosphate
9%
Tunicamycin
9%
Antibody Affinity
9%
Polyclonal Antibody
9%
Dimerization
9%
Chorion Villus
9%